CompletedNCT01911676
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 21 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT03037983
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
CompletedNCT00878462
This study exists to learn from real-world information that can show how the medication Unflavored fits into care. Researchers are trying to understand how people respond to the medication Unflavored in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT00151424
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT00156104
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT00212784
This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT00156117
This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT04673851
This study exists to see whether a guided support group is workable and worth testing more broadly. Researchers are trying to understand whether a guided support group can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 16 Years to 35 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
CompletedNCT04748679
This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand what cognitive behavioural therapy, a structured talking treatment, can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Vanderbilt University Medical Center
- Condition
- Schizophrenia
CompletedNCT01006551
This study exists to see whether a medication treatment is workable and worth testing more broadly. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 6 Years to 19 Years
- Countries
- United States
- Sponsor
- University of North Carolina, Chapel Hill
- Condition
- Schizophrenia
CompletedNCT00212836
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Global
- Sponsor
- Organon and Co
- Condition
- Schizophrenia
CompletedNCT03730831
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Germany
- Sponsor
- University of Konstanz
- Condition
- Schizophrenia
CompletedNCT04972227
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- Tisento Therapeutics
- Condition
- Schizophrenia
TerminatedNCT03669640
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Japan, Spain, Ukraine, United States
- Sponsor
- Hoffmann-La Roche
- Condition
- Schizophrenia
Not Yet RecruitingNCT06546475
This study exists to compare options and see whether the medication Tapering offers something meaningfully different. Researchers are trying to understand whether the medication Tapering can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Global
- Sponsor
- National Taiwan University Hospital
- Condition
- Schizophrenia
CompletedNCT03829280
This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- The University of Texas Health Science Center at San Antonio
- Condition
- Schizophrenia
WithdrawnNCT05870384
This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can better support energy, concentration, and everyday functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Abant Izzet Baysal University
- Condition
- Schizophrenia
CompletedNCT06538259
This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 19 Years to 60 Years
- Countries
- China
- Sponsor
- Northeast Normal University
- Condition
- Schizophrenia
CompletedNCT04118127
This study exists to better understand the safety of the medication Brexpiprazole and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Brexpiprazole in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- Japan
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Condition
- Schizophrenia
TerminatedNCT04210557
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
CompletedNCT06527885
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 99 Years
- Countries
- Italy
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
- Condition
- Schizophrenia
Not Yet RecruitingNCT06471179
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 40 Years
- Countries
- Global
- Sponsor
- Assiut University
- Condition
- Schizophrenia
CompletedNCT02067975
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- University of Maryland, Baltimore
- Condition
- Schizophrenia
WithdrawnNCT05389345
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
RecruitingNCT06361160
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherOver 18 Years
- Countries
- France
- Sponsor
- Centre Hospitalier St Anne
- Condition
- Schizophrenia